APA (7th ed.) Citation

Englisch, S., Morgen, K., Meyer-Lindenberg, A., & Zink, M. (2013). Risks and benefits of bupropion treatment in schizophrenia: A systematic review of the current literature. Clinical neuropharmacology, 36(6), . https://doi.org/10.1097/WNF.0b013e3182a8ea04

Chicago Style (17th ed.) Citation

Englisch, Susanne, Katrin Morgen, Andreas Meyer-Lindenberg, and Mathias Zink. "Risks and Benefits of Bupropion Treatment in Schizophrenia: A Systematic Review of the Current Literature." Clinical Neuropharmacology 36, no. 6 (2013). https://doi.org/10.1097/WNF.0b013e3182a8ea04.

MLA (9th ed.) Citation

Englisch, Susanne, et al. "Risks and Benefits of Bupropion Treatment in Schizophrenia: A Systematic Review of the Current Literature." Clinical Neuropharmacology, vol. 36, no. 6, 2013, https://doi.org/10.1097/WNF.0b013e3182a8ea04.